Last reviewed · How we verify
Multi-center Study Evaluating OraVescent Fentanyl Citrate for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl when used long-term to relieve breakthrough pain in opioid tolerant cancer patients.
Details
| Lead sponsor | Cephalon |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Enrolment | 100 |
| Start date | 2005-01 |
| Completion | 2007-09 |
Conditions
- Pain
- Cancer
Interventions
- OraVescent fentanyl (OVF)
Countries
United States